View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
May 3, 2022

Logistics challenges will reduce the delivery of essential medical devices in Russia

The ongoing war in Ukraine has created numerous logistical challenges that will impact the delivery of medical devices to Russia.

By GlobalData Healthcare

The Russian healthcare system relies on imported medical devices to fill gaps where domestic supply is unavailable. This trend is best observed in tech-heavy device sectors where leading international brands are often imported into Russia for use in private and public facilities. Devices deemed essential to the Russian healthcare system have been exempt from Western export restrictions based on humanitarian need, but nonetheless, the ongoing war in Ukraine has created numerous logistical challenges that will impact their delivery.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The logistics of shipping essential goods such as medical devices into Russia has become an increasingly complex process during the conflict. Many land shipping routes through Russia, Belarus and Ukraine have become too dangerous for operation and have been effectively closed. Freight-forwarding companies have had to redirect shipments through slower and less efficient routes in nearby countries like Serbia, Latvia and Turkey.

Air and maritime cargo channels have also faced setbacks due to safety concerns in the Black Sea, insurance rate hikes, rising fuel costs and airspace restrictions throughout the region. This translates into reduced import volumes, increased costs, and delays to the delivery of many imported goods into Russia, including medical devices. For import-heavy Russian medical device markets such as patient monitoring and diagnostic imaging, GlobalData predicts a market contraction of 54% and 46%, respectively, for this year.

As supply chain issues mount and global device manufacturers limit their activities in the region, Russia has made efforts to stabilise its medical device imports by streamlining regulatory processes to prevent inventory shortages. In early April, the Russian government announced the possibility of a list of medical devices that could become eligible for an expedited registration process. Devices included on this list could be eligible for shortened review timelines and simplified registration dossier requirements, but the proposed device list has not yet been published. Whether this will be sufficient to prevent inventory shortages in the long term is still to be determined.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Related Report
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network